Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for General Anesthesia Induction in Elderly Trigeminal Neuralgia Patients
ChiCTR2500106032Phase 4Recruiting
- Sponsor
- Jiangxi Provincial People's Hospital
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in trigeminal neuralgia (TN) (2 arms), sponsored by Jiangxi Provincial People's Hospital. Primary endpoint: Depressive symptoms. Started Jul 2025; status: recruiting.
02
Drugs
esketamine
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on ChiCTR2500106032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500106032.